Market Access/Orphan Medicines Group
The Market Access Group aims to:
- reduce the hurdles to uptake in the UK and enable innovative products to reach patients in a timely manner
- identify cost-effective solutions to market access challenges
- work with government and officials to communicate solutions to market access challenges
- understand the impact on the varied range of EMIG member companies (biotechs to mature companies) of gaining market access in the UK.
About the Chair
Market Access Group Events